The v-rel and c-rel proteins exist in high molecular weight complexes in avian and murine cells.

Abstract:

:We reported previously that the v-rel protein (p59v-rel) exists in a high molecular weight complex with at least four other proteins in the cytoplasm of v-rel-transformed chicken pre-B lymphoid cells (Simek, S. & Rice, N.R., J. Virol., 62, 4730-4736, 1989). One of these proteins is the chicken c-rel protein, but the identities of the others (of about 36 kDa, 115 kDa, and 124 kDa) are unknown. In this report we extend that observation to additional v-rel-transformed cell lines of both pre-B and B cell phenotypes. We also introduced and expressed v-rel in several other avian cell lines (a chicken T cell line, chick embryo fibroblasts, and quail fibroblasts) and found that in these cells p59v-rel was complexed with the same proteins as observed in the v-rel-transformed cells. Thus, the associated proteins are not limited to pre-B cells, but occur and complex with p59v-rel in B cells, T cells, and fibroblasts. We next examined five uninfected avian cells and tissues and found that, with only one exception, p75c-rel was complexed with p36, p115, and p124. Thus, in most cases complex formation is not limited to or dependent on the presence of the transforming v-rel protein, but also occurs with the normal c-rel protein. To determine whether a mammalian c-rel protein is similarly associated with other proteins, we screened murine cell lines for the presence of c-rel mRNA. In agreement with our earlier findings, we found the highest expression in mature B cells, although several pre-B and myeloid cell lines were also strongly positive. Using one of the B cell lines, we detected the murine c-rel protein. We found that, like its avian counterpart, it is a protein of about 75 kDa and is associated with proteins of 36 kDa and 115 kDa. Sephacryl S-400 chromatography revealed that both the avian and murine complexes are of high molecular weight, with an average size of about 400 kDa.

journal_name

Oncogene

journal_title

Oncogene

authors

Kochel T,Mushinski JF,Rice NR

subject

Has Abstract

pub_date

1991-04-01 00:00:00

pages

615-26

issue

4

eissn

0950-9232

issn

1476-5594

journal_volume

6

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Studying the pathogenesis of BCR-ABL+ leukemia in mice.

    abstract::Animal models of BCR-ABL+ leukemias have provided important new knowledge about the molecular pathophysiology of these diseases, and answered questions that are difficult or impossible to address using BCR-ABL-expressing cell lines or primary Ph+ leukemia samples from patients. The power of mouse models lies in their ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1206091

    authors: Van Etten RA

    更新日期:2002-12-09 00:00:00

  • Human papillomavirus E7 proteins stimulate proliferation independently of their ability to associate with retinoblastoma protein.

    abstract::Studies on human papillomavirus type 16 have demonstrated that the product of the early gene, E7, plays a key role in the immortalization and malignant transformation of the host cell. Several of the biological activities of HPV16 E7 are mediated by inactivation of the members of the pocket protein family, pRb, p107 a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203375

    authors: Caldeira S,de Villiers EM,Tommasino M

    更新日期:2000-02-10 00:00:00

  • Rho GTPases: Anti- or pro-neoplastic targets?

    abstract::Rho GTPases are critical signal transducers of multiple pathways. They have been proposed to be useful anti-neoplastic targets for over two decades, especially in Ras-driven cancers. Until recently, however, few in vivo studies had been carried out to test this premise. Several recent mouse model studies have verified...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2016.473

    authors: Zandvakili I,Lin Y,Morris JC,Zheng Y

    更新日期:2017-06-08 00:00:00

  • Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation.

    abstract::p27 restrains normal cell growth, but PI3K-dependent C-terminal phosphorylation of p27 at threonine 157 (T157) and T198 promotes cancer cell invasion. Here, we describe an oncogenic feedforward loop in which p27pT157pT198 binds Janus kinase 2 (JAK2) promoting STAT3 (signal transducer and activator of transcription 3) ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.473

    authors: Zhao D,Besser AH,Wander SA,Sun J,Zhou W,Wang B,Ince T,Durante MA,Guo W,Mills G,Theodorescu D,Slingerland J

    更新日期:2015-10-01 00:00:00

  • Androgen receptor promotes melanoma metastasis via altering the miRNA-539-3p/USP13/MITF/AXL signals.

    abstract::Early studies demonstrated that male melanoma patients have worse survival than female patients, yet the detailed mechanisms for this gender difference remain unclear. We analyzed around 100 cases of human melanoma and found that androgen receptor (AR) positive melanoma patients have worse survival outcomes compared w...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.330

    authors: Wang Y,Ou Z,Sun Y,Yeh S,Wang X,Long J,Chang C

    更新日期:2017-03-23 00:00:00

  • Rap1A protein interferes with various MAP kinase activating pathways in skeletal myogenic cells.

    abstract::Constitutive expression of the activated Rap1A protein inhibits differentiation of myogenic C2 cells whereas the inactivated Rap1A protein favours cell differentiation and induces late endocytic compartments clustering. Although the role of Rap1A in MAPK activation has been analysed in various cell types, the signalli...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203984

    authors: Pizon V,Baldacci G

    更新日期:2000-12-07 00:00:00

  • CHK2 stability is regulated by the E3 ubiquitin ligase SIAH2.

    abstract::The serine threonine checkpoint kinase 2 (CHK2) is a critical protein involved in the DNA damage-response pathway, which is activated by phosphorylation inducing cellular response such as DNA repair, cell-cycle regulation or apoptosis. Although CHK2 activation mechanisms have been amply described, very little is known...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.495

    authors: García-Limones C,Lara-Chica M,Jiménez-Jiménez C,Pérez M,Moreno P,Muñoz E,Calzado MA

    更新日期:2016-08-18 00:00:00

  • NF-kappaB signaling, liver disease and hepatoprotective agents.

    abstract::The NF-kappaB signaling pathway has particular relevance to several liver diseases including hepatitis (liver infection by Helicobacter, viral hepatitis induced by HBV and HCV), liver fibrosis and cirrhosis and hepatocellular carcinoma. Furthermore, the NF-kappaB signaling pathway is a potential target for development...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2008.300

    authors: Sun B,Karin M

    更新日期:2008-10-20 00:00:00

  • The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain.

    abstract::The E6 proteins of specific cancer-associated human papillomaviruses (HPVs) complex with and mediate degradation of the cellular anti-oncogene p53 in vitro. A critical property of p53 is its ability to stimulate transcription from promoters containing its recognition sequence. HPV E6, mutant p53 proteins, and several ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Mansur CP,Marcus B,Dalal S,Androphy EJ

    更新日期:1995-02-02 00:00:00

  • Uracil in DNA--occurrence, consequences and repair.

    abstract::Uracil in DNA results from deamination of cytosine, resulting in mutagenic U : G mispairs, and misincorporation of dUMP, which gives a less harmful U : A pair. At least four different human DNA glycosylases may remove uracil and thus generate an abasic site, which is itself cytotoxic and potentially mutagenic. These e...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1205996

    authors: Krokan HE,Drabløs F,Slupphaug G

    更新日期:2002-12-16 00:00:00

  • Role of the integrin-linked kinase (ILK)/Rictor complex in TGFβ-1-induced epithelial-mesenchymal transition (EMT).

    abstract::Epithelial-to-mesenchymal transition (EMT) causes fibrosis, cancer progression and metastasis. Integrin-linked kinase (ILK) is a focal adhesion adaptor and a serine/threonine protein kinase that regulates cell proliferation, survival and EMT. Elucidating the molecular mechanisms necessary for development and progressi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.30

    authors: Serrano I,McDonald PC,Lock FE,Dedhar S

    更新日期:2013-01-03 00:00:00

  • Transforming growth factor-beta 1 inhibits cyclin D1 expression in intestinal epithelial cells.

    abstract::Transforming growth factor-beta 1 (TGF-beta 1) inhibits most epithelial cell types by blocking cell cycle progression during the G1 phase. D cyclins are normally expressed during G1 and are regulators of G1 progression. One of the crucial functions of D cyclins is their ability to bind to a cyclin-dependent kinase (Cd...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Ko TC,Sheng HM,Reisman D,Thompson EA,Beauchamp RD

    更新日期:1995-01-05 00:00:00

  • THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.

    abstract::Promyelocytic leukemia (PML) nuclear bodies (PML NBs) are discrete subnuclear domains organized by the promyelocytic leukemia protein PML, a tumor suppressor essential for multiple apoptotic pathways. We have recently described a novel family of cellular factors, the THAP proteins, characterized by the presence at the...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206271

    authors: Roussigne M,Cayrol C,Clouaire T,Amalric F,Girard JP

    更新日期:2003-04-24 00:00:00

  • Artemis is a negative regulator of p53 in response to oxidative stress.

    abstract::Artemis is a multifunctional phospho-protein with roles in V(D)J recombination, repair of double-strand breaks by nonhomologous end-joining and regulation of cell-cycle checkpoints after DNA damage. Here, we describe a new function of Artemis as a negative regulator of p53 in response to oxidative stress in both prima...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.100

    authors: Zhang X,Zhu Y,Geng L,Wang H,Legerski RJ

    更新日期:2009-06-04 00:00:00

  • Prolyl isomerase Pin1 stabilizes and activates orphan nuclear receptor TR3 to promote mitogenesis.

    abstract::Pin1 regulates a subset of phosphoproteins by isomerizing phospho-Ser/Thr-Pro motifs via a 'post-phosphorylation' mechanism. Here, we characterize TR3 as a novel Pin1 substrate, and the mitogenic function of TR3 depends on Pin1-induced isomerization. There are at least three phospho-Ser-Pro motifs on TR3 that bind to ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.463

    authors: Chen HZ,Li L,Wang WJ,Du XD,Wen Q,He JP,Zhao BX,Li GD,Zhou W,Xia Y,Yang QY,Hew CL,Liou YC,Wu Q

    更新日期:2012-06-07 00:00:00

  • LNC942 promoting METTL14-mediated m6A methylation in breast cancer cell proliferation and progression.

    abstract::Increasing evidence supports that long noncoding RNAs (lncRNAs) act as master regulators involved in tumorigenesis and development at the N6-methyladenine (m6A) epigenetic modification level. However, the underlying regulatory mechanism in breast cancer (BRCA) remains elusive. Here, we unveil that LINC00942 (LNC942) e...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-1338-9

    authors: Sun T,Wu Z,Wang X,Wang Y,Hu X,Qin W,Lu S,Xu D,Wu Y,Chen Q,Ding X,Guo H,Li Y,Wang Y,Fu B,Yao W,Wei M,Wu H

    更新日期:2020-07-01 00:00:00

  • C/EBP-δ regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1α.

    abstract::CCAAT/enhancer-binding protein-δ (C/EBP-δ), a transcription factor, is elevated in carcinoma compared with that in normal tissue. This study reports a novel function of C/EBP-δ in lymphangiogenesis and tumor metastasis. Genetic deletion of C/EBP-δ in mice resulted in a significant reduction of lymphangiogenesis and pu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.187

    authors: Min Y,Ghose S,Boelte K,Li J,Yang L,Lin PC

    更新日期:2011-12-08 00:00:00

  • The HIF and other quandaries in VHL disease.

    abstract::Mutations in VHL underlie von Hippel-Lindau (VHL) disease, a hereditary cancer syndrome with several subtypes depending on the risk of developing certain combination of classic features, such as clear cell renal cell carcinoma (ccRCC), hemangioblastoma and pheochromocytoma. Although numerous potential substrates and f...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2017.338

    authors: Tarade D,Ohh M

    更新日期:2018-01-11 00:00:00

  • Efficient replication of plasmids containing the SV40 origin in N-myc overexpressing human neuroblastoma cells.

    abstract::Using test plasmids containing the SV40 origin, we found a wide spectrum of permissiveness to their replication in different human cell lines. N-myc overexpressing neuroblastoma cells were highly permissive. LA-N-1 neuroblastoma cells were the most permissive of all the cell lines that we tested including the homologo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Lee NG,Yamaguchi J,Subramanian KN

    更新日期:1991-07-01 00:00:00

  • The MutSβ complex is a modulator of p53-driven tumorigenesis through its functions in both DNA double-strand break repair and mismatch repair.

    abstract::Loss of the DNA mismatch repair (MMR) protein MSH3 leads to the development of a variety of tumors in mice without significantly affecting survival rates, suggesting a modulating role for the MutSβ (MSH2-MSH3) complex in late-onset tumorigenesis. To better study the role of MSH3 in tumor progression, we crossed Msh3(-...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.365

    authors: van Oers JM,Edwards Y,Chahwan R,Zhang W,Smith C,Pechuan X,Schaetzlein S,Jin B,Wang Y,Bergman A,Scharff MD,Edelmann W

    更新日期:2014-07-24 00:00:00

  • Hyperactivation of EGFR and downstream effector phospholipase D1 by oncogenic FAM83B.

    abstract::Despite the progress made in targeted anticancer therapies in recent years, challenges remain. The identification of new potential targets will ensure that the arsenal of cancer therapies continues to expand. FAM83B was recently discovered in a forward genetic screen for novel oncogenes that drive human mammary epithe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.293

    authors: Cipriano R,Bryson BL,Miskimen KL,Bartel CA,Hernandez-Sanchez W,Bruntz RC,Scott SA,Lindsley CW,Brown HA,Jackson MW

    更新日期:2014-06-19 00:00:00

  • Expression of alpha-catenin in alpha-catenin-deficient cells results in a reduced proliferation in three-dimensional multicellular spheroids but not in two-dimensional monolayer cultures.

    abstract::alpha-Catenin is an intracellular protein that associates with the carboxy-terminal region of cadherin, a cell adhesion molecule, via beta-catenin or gamma-catenin (plakoglobin). Linkage of cadherin to the cytoskeleton by catenins is required for full cadherin activity. Following transfection of an alpha-catenin-defic...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207423

    authors: Matsubara S,Ozawa M

    更新日期:2004-04-08 00:00:00

  • Mouse Neogenin, a DCC-like molecule, has four splice variants and is expressed widely in the adult mouse and during embryogenesis.

    abstract::Neogenin is a member of the N-CAM family of cell adhesion molecules and is closely related to the DCC tumor suppressor gene product. Recently, it has been demonstrated that the DCC/Neogenin subfamily plays a key role in axonal guidance within the embryonic nervous system, however little is known about the function of ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201225

    authors: Keeling SL,Gad JM,Cooper HM

    更新日期:1997-08-07 00:00:00

  • Ubiquilin1 represses migration and epithelial-to-mesenchymal transition of human non-small cell lung cancer cells.

    abstract::Ubiquilin1 (UBQLN1) is a ubiquitin-like domain and a ubiquitin-associated domain containing protein that has been reported to be involved in shuttling proteins to the proteasome, especially during endoplasmic reticulum-associated protein degradation. Thus, UBQLN1 function has been shown to be critical for combating a ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.97

    authors: Shah PP,Lockwood WW,Saurabh K,Kurlawala Z,Shannon SP,Waigel S,Zacharias W,Beverly LJ

    更新日期:2015-03-26 00:00:00

  • Post-transcriptional inactivation of p53 in immortalized murine embryo fibroblast cells.

    abstract::The steady-state levels of p53 mRNA and protein were barely detectable by Northern and Western blot analysis in spontaneously immortalized (10)3 and (10)7 murine embryo fibroblast (MEF) cells. But when cells were treated with cycloheximide (CHX) or emetine, expression levels were restored to those observed in primary ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204423

    authors: Kim H,You S,Farris J,Foster LK,Foster DN

    更新日期:2001-05-31 00:00:00

  • MASL1, a candidate oncogene found in amplification at 8p23.1, is translocated in immunoblastic B-cell lymphoma cell line OCI-LY8.

    abstract::Genetic amplification at chromosome 8p23.1 has been reported in some solid tumors. Translocation of 8p23.1 has also been reported in hematological malignancies and head and neck squamous cell cancer. In an attempt to clarify whether this translocation is implicated in lymphomagenesis, we performed FISH analysis of the...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207352

    authors: Tagawa H,Karnan S,Kasugai Y,Tuzuki S,Suzuki R,Hosokawa Y,Seto M

    更新日期:2004-04-01 00:00:00

  • CD4 and p56lck can stably associate when co-expressed in NIH3T3 cells.

    abstract::The CD4 T-cell surface antigen and the lymphocyte-specific tyrosine-protein kinase p56lck form a stable noncovalent complex in CD4+ T-lymphocytes. In this report, we demonstrate that these two gene products can also associate when co-expressed in NIH3T3 fibroblasts, therefore implying that other lymphoid specific comp...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Simpson SC,Bolen JB,Veillette A

    更新日期:1989-09-01 00:00:00

  • A novel p53 germline alteration identified in a late onset breast cancer kindred.

    abstract::Germline mutations in the p53 tumor suppressor gene are associated with the Li-Fraumeni syndrome, characterized by childhood sarcoma, leukemia and early onset breast cancer and has occasionally been found also in familial breast-ovarian cancer. Most mutations found are of missense type and located in the central regio...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Sun XF,Johannsson O,Håkansson S,Sellberg G,Nordenskjöld B,Olsson H,Borg A

    更新日期:1996-07-18 00:00:00

  • Random mutagenesis of PDZ(Omi) domain and selection of mutants that specifically bind the Myc proto-oncogene and induce apoptosis.

    abstract::Omi is a mammalian serine protease that is localized in the mitochondria and released to the cytoplasm in response to apoptotic stimuli. Omi induces cell death in a caspase-dependent manner by interacting with the X-chromosome linked inhibitor of apoptosis protein, as well as in a caspase-independent way that relies o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206359

    authors: Junqueira D,Cilenti L,Musumeci L,Sedivy JM,Zervos AS

    更新日期:2003-05-08 00:00:00

  • Copine-III interacts with ErbB2 and promotes tumor cell migration.

    abstract::ErbB2 amplification and overexpression in breast cancer correlates with aggressive disease and poor prognosis. To find novel ErbB2-interacting proteins, we used stable isotope labeling of amino acids in cell culture followed by peptide affinity pull-downs and identified specific binders using relative quantification b...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.456

    authors: Heinrich C,Keller C,Boulay A,Vecchi M,Bianchi M,Sack R,Lienhard S,Duss S,Hofsteenge J,Hynes NE

    更新日期:2010-03-18 00:00:00